The Efficacy of Ticagrelor on Abdominal Aortic Aneurysm (AAA) Expansion
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
Abdominal aortic aneurysm (AAA) is a major health problem and ruptured AAA is a common cause
of death in Europe and North America. A key limitation of contemporary treatment strategies
of AAA is the lack of therapy directed at reducing expansion. Although surgical repair is an
effective treatment for large AAA, it is associated with significant mortality and morbidity
as well as substantial cost. The rationale for this randomized controlled study is to
investigate whether treatment with Ticagrelor inhibits growth of small abdominal aortic
aneurysms.